GlassScriptPhysician profile
Rajiv Gupta
NPI 1164425526
$2,051.57
in general payments reported to CMS, 2019-2025
19 companies · $130 in 2025
The $130 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $969 · 2020: $49.82 · 2021: $84.44 · 2022: $265 · 2023: $286 · 2024: $267 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $817.70 | 2019-2024 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Seqirus USA INC | $196.00 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent |
| Glaxosmithkline, LLC. | $177.76 | 2019-2025 | Bexsero, Pediarix, Menveo |
| Ironshore Pharmaceuticals INC. | $142.24 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $122.96 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Cranial Technologies, INC | $84.22 | 2019-2023 | Doc Band |
| Teva Pharmaceuticals USA, INC. | $80.98 | 2019 | |
| Sanofi-Aventis U.S. LLC | $72.20 | 2024-2025 | |
| Sanofi Pasteur INC. | $59.31 | 2019-2024 | |
| Pfizer INC. | $57.24 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.08 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $39.24 | 2023 | Flumist Quadrivalent |
| Supernus Pharmaceuticals, INC. | $35.15 | 2021 | |
| Corium, LLC | $32.57 | 2022-2023 | Azstarys |
| Ultragenyx Pharmaceutical INC. | $26.48 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cognoa, INC. | $16.54 | 2022 | |
| Collegium Pharmaceutical, INC. | $14.54 | 2025 | Jornay Pm |
| Genentech USA, INC. | $12.22 | 2020 | |
| Shire North American Group INC | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajiv Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.